Up&Up loratadine orally disintegrating tablets recall: Superpotent
Up&Up loratadine orally disintegrating tablets, USP, 10 mg, 30-count tablets per box, Distributed by Target Corp, Minneapolis, MN 55403; NDC 11673-527-31, UPC 3 5166052731 5
Why was Up&Up loratadine orally disintegrating tablets recalled?
Superpotent Drug: Out Of Specification (OOS) result for Assay.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Batch Numbers: 2617892, 2617893, Exp 5/31/2016; 2625092, 2625093, Exp 6/30/2016; 2658137, 2658138, Exp 11/30/2016
- Product
- Up&Up loratadine orally disintegrating tablets, USP, 10 mg, 30-count tablets per box, Distributed by Target Corp, Minneapolis, MN 55403; NDC 11673-527-31, UPC 3 5166052731 5
- Recalling firm
- Ohm Laboratories, Inc.
- Quantity
- 34,488 boxes
- Distribution
- Nationwide.
- Recall date
- October 21, 2015
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)